Ingevity Corp buy BMO Capital Markets
Start price
05.09.25
/
50%
€51.00
Target price
05.09.26
€58.30
Performance (%)
26.86%
Price
23.02.26
€60.20
Summary
This prediction is currently active. The prediction currently has a performance of 26.86%. This prediction currently runs until 05.09.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ingevity Corp | -6.011% | -6.011% |
| iShares Core DAX® | 1.432% | 1.580% |
| iShares Nasdaq 100 | 1.892% | -2.280% |
| iShares Nikkei 225® | -1.619% | 7.954% |
| iShares S&P 500 | 1.921% | -0.277% |
Comments by BMO_Capital_Markets for this prediction
In the thread Ingevity Corp diskutieren
Ingevity (NYSE:NGVT) had its price target raised by analysts at BMO Capital Markets from $62.00 to $68.00. They now have an "outperform" rating on the stock.
Ratings data for NGVT provided by MarketBeat